Trial intelligence / Profile preview

Amiloride in Coronary Artery Disease

NCT01228214Phase 3Unknown

Sponsor
Universidad de Carabobo
Start
Mar 2011
Primary completion
Apr 2013
Countries
1
01

Overview

A Phase 3 trial of amiloride in coronary artery disease (CAD), sponsored by Universidad de Carabobo. Status: unknown.

02

Drugs

amiloride
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01228214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01228214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call